Related Experiment Videos

Recurrence of membranous nephropathy three weeks' postrenal transplant: A surprise in store

Arun Narayanan Kumar1, Praveen Murlidharan1, Sandeep Patil1

  • 1Department of Nephrology, Kerala Institute of Medical Sciences, Trivandrum, Kerala, India.

Insights

Membranous nephropathy (MN) can recur in kidney transplants, sometimes very early after surgery. This recurrence poses a significant risk to the transplanted kidney

Area of Science:

  • Nephrology
  • Transplant Medicine
  • Immunology

Background:

  • Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
  • MN can affect native kidneys and also occur in kidney allografts, either recurrently or de novo.
  • Recurrent MN in kidney transplants is a significant concern, potentially leading to graft loss.

Observation:

  • The incidence of recurrent MN post-kidney transplantation ranges from 10% to 45%.
  • Clinical symptoms of recurrent MN typically appear 13-15 months post-transplant.
  • In this case, MN recurrence was observed unusually early, within three weeks of transplantation.

Findings:

  • Early recurrence of membranous nephropathy in a kidney allograft was documented.
  • The patient presented with symptoms of recurrent MN significantly sooner than the typical timeframe.

Implications:

  • Early detection and management of recurrent MN are crucial for allograft survival.
  • Understanding the timelines of MN recurrence can inform post-transplant monitoring strategies.
  • This case highlights the potential for rapid recurrence, emphasizing the need for vigilance in transplant recipients.

Related Concept Videos